Press "Enter" to skip to content

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial – P&T Community

admin 0

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial  P&T Community

PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today …

“nigeria cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your e-mail address will not be published. Required fields are marked *